Rigel Pharmaceuticals RIGL
NASDAQ RIGL
$48.29 +0.14 (+0.30%)
As of: Oct 1, 2026 · 12:07 PM EDT

Rigel Pharmaceuticals (RIGL) Gross Profit (2018 - 2026)

Updated

Rigel Pharmaceuticals (RIGL) posted Gross Profit of $70.18 million for Q2 2026, down 27.8% from $97.18 million a year earlier but up 29.5% from the prior quarter.

Analysis

Rigel Pharmaceuticals (RIGL) Gross Profit (2018 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Gross Profit at Rigel Pharmaceuticals was $252.95 million, up 3.2% year-over-year; for FY2025, it was $274.66 million, up 71.0% from FY2024.

  • Annual Gross Profit shows a five-year compound annual growth rate of 20.6% (FY2020 to FY2025).
  • In prior years, Rigel Pharmaceuticals' Gross Profit was $160.63 million in FY2024 (+46.3%), $109.77 million in FY2023 (-7.4%), $118.49 million in FY2022 (-20.0%) and $148.15 million in FY2021 (+37.5%).
  • Quarterly Gross Profit has run from a low of $16.61 million in Q1 2022 to a high of $97.18 million in Q2 2025 over five years.
  • On a year-over-year basis, Gross Profit increased in seven of the last eight quarters, with growth averaging 55.5%.
  • The strongest year-over-year quarter for Gross Profit in the past five years was Q2 2025, with growth of 185.5%; the weakest was Q1 2022, with a decline of 79.4%.
  • According to Business Quant data, Gross Profit for the three prior quarters was $54.21 million (Q1 2026), $63.85 million (Q4 2025) and $64.71 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
API Access

Rigel Pharmaceuticals Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=RIGL&period=max&api_key=YOUR_API_KEY